AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -4.0% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | — | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | — | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | — | — |
| Q2 2024 | 11 | — | 2.57M | $51.15M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 1.96M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 1.04M | -1.2% | $16.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 1.04M | -1.2% | $16.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 494.63K | +43.1% | $7.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 494.63K | +43.1% | $7.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 259.42K | -43.0% | $4.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passiv) | 104.50K | -40.0% | $1.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 90.04K | -21.7% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 72.70K | +20.6% | $1.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 64.77K | Neu | $1.03M | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 64.77K | Neu | $1.03M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 44.91K | -31.1% | $715,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 33.42K | -66.2% | $532,015 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 28.23K | +5.3% | $449,485 | 0.0% | ▲ Add | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Marshall Wace | $1.03M | 0.0% |
| Marshall Wace | $1.03M | 0.0% |
Ausgestiegen
| Bridgewater Associates | $251,618 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 255 Inhaber, 44.71M Anteile, $512.85M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.